Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trilogy International Partners Inc T.TRL.WT.A


Primary Symbol: V.TRL.H

Trilogy International Partners Inc. operates through its subsidiary Trilogy International Partners LLC (Trilogy LLC). Prior to the disposal of its New Zealand and Bolivia operations, Trilogy LLC was a provider of wireless voice and data communications services including local, international long distance and roaming services. Trilogy LLC also provided fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia. The Company had two reportable segments identified by their geographic regions, New Zealand and Bolivia. Two Degrees Mobile Limited (2degrees) operated in New Zealand and Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A. (NuevaTel) operated in Bolivia. Both these segments provided a variety of wireless voice and data communications services, including local, international long distance and roaming services. The services were provided to subscribers on both a postpaid and prepaid basis.


TSXV:TRL.H - Post by User

Comment by TankRebel2012on Mar 06, 2019 12:17am
67 Views
Post# 29447682

RE:RE:RE:RE:RE:RE:RE:RE:RE:Avanafil NDS

RE:RE:RE:RE:RE:RE:RE:RE:RE:Avanafil NDS No PP is needed once the Europe approval happens, the deal was once approved by health agency they will get a large lump sum of money which is due soon (like 15m dollars canadian i believe)... no idea the timeframe but since it been over a year or more it's in due time... that should fund the company future growth.  over 70 countries and korea no other product is in that market so 100% market control plus largest health pharm in korea... plus plus.  Aytu was a quick bad pick to  market it to USA.  No resupply orders come in awful....    This a great long term pick. been playing it for the last three years..... ins and outs. 

mackies research still holding a 60 cent price target.


Bullboard Posts